Early Natural Killer Cell Reconstitution Predicts Overall Survival in T Cell–Replete Allogeneic Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Early Natural Killer Cell Reconstitution Predicts Overall Survival in T Cell–Replete Allogeneic Hematopoietic Stem Cell Transplantation

Published:2016-12 Issue:12 Volume:22 Page:2187-2193
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Minculescu Lia,Marquart Hanne Vibeke,Friis Lone Smidstrup,Petersen Soeren Lykke,Schiødt Ida,Ryder Lars Peter,Andersen Niels Smedegaard,Sengeloev Henrik

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference35 articles.

1. Hematopoietic stem-cell transplantation;Copelan;N Engl J Med,2006

2. Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome;Kim;Biol Blood Marrow Transplant,2015

3. Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies;Le;Biol Blood Marrow Transplant,2009

4. Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation;Savani;Biol Blood Marrow Transplant,2007

5. Peripheral blood lymphocyte and monocyte recovery and survival in acute leukemia postmyeloablative allogeneic hematopoietic stem cell transplant;Thoma;Biol Blood Marrow Transplant,2012

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of “day 90” CD4+ T cells on clinical outcomes in children with relapsed/refractory acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation;Transplant Immunology;2024-10

2. Early recovery of natural killer cells post T-cell depleted allogeneic stem cell transplantation using alemtuzumab “in the bag”;Transplant Immunology;2024-06

3. Evolution of natural killer cell-targeted therapy for acute myeloid leukemia;International Journal of Hematology;2024-05-01

4. The Influence of KIR Gene Polymorphisms and KIR-ligand Binding on Outcomes in Hematologic Malignancies following Haploidentical Stem Cell Transplantation: A Comprehensive Review;Current Cancer Drug Targets;2023-12

5. Cell therapy with IL-10-producing group 2 innate lymphoid cells suppresses Graft-versus-Host disease;2023-08-22